Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Teens with cancer test wearable tech to fight fatigue

NCT ID NCT07337681

Symptom relief Sponsor: Istanbul University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a wearable activity tracker and guided exercise app can reduce fatigue and improve quality of life in teens aged 13-18 who are undergoing cancer treatment. Half of the 50 participants will follow an 8-week structured exercise program using the wearable, while the other half receives standard care with passive monitoring only. Fatigue and well-being will be measured before, during, and after the program.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
wearable technology-supported exercise program
What this could lead to
If it works, this could offer a safe, home-based way to ease fatigue and improve daily life for teens undergoing cancer treatment.
What could go wrong
This is a small, early-stage trial (50 participants) testing feasibility. The exercise program may be hard to stick with, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 13 to 18 years. * Diagnosed with cancer and followed at a pediatric hematology-oncology clinic. * Currently receiving active cancer treatment and has completed at least one cycle of chemotherapy. * Clinically stable and medically cleared by the treating physician to participate in low-to-moderate intensity exercise. * Able to understand instructions and communicate verbally. * Willing to participate in at least 75% of the prescribed exercise sessions. * Written informed consent obtained from a parent or legal guardian and assent obtained from the participant. Exclusion Criteria: * Presence of acute infection, uncontrolled cardiac or pulmonary disease, respiratory failure, or uncontrolled hypertension. * Severe neurological, psychiatric, or musculoskeletal conditions that limit safe participation in exercise. * Persistent thrombocytopenia (\<10,000/µL) or known coagulation disorders. * Uncontrolled seizure disorders. * Central nervous system metastases. * Any medical or psychological condition deemed by the treating physician to contraindicate exercise participation or compromise study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer-related fatigue are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm Motor Activity neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer-related fatigue Exercise Pediatric cancer Quality of life

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.